Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Stemcyte, Inc.

Clinical trials sponsored by Stemcyte, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Cord blood infusion trial aims to beat long COVID fatigue Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

Cord blood infusion now available for long COVID patients under expanded access

Disease control Expanded access

This expanded access program offers REGENECYTE, a human umbilical cord blood infusion, to adults with Long COVID who cannot join other clinical trials. Participants must have a recent negative COVID-19 test and provide consent. The goal is to provide potential treatment access wh…

Sponsor: StemCyte, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC